Sarcoma | Topics

FDA Grants Fast Track Designation to Investigational Anthracycline Annamycin for STS Lung Metastases
March 30, 2021

The agent annamycin, which offers the potential to fulfill unmet medical needs of traditional anthracyclines, has been granted fast track designation for the treatment of soft tissue sarcoma lung metastases.

Study Finds Niraparib Plus Temozolomide or Irinotecan Tolerable in Pretreated Ewing Sarcoma
February 06, 2021

Based on findings from a study looking at niraparib plus cytotoxic agents, investigators have commenced a combination study of the niraparib plus temozolomide and irinotecan triplet in patients with pretreated Ewing sarcoma.

Neoadjuvant Systemic Therapy Induces Fair Response Rate for High-Risk Retroperitoneal Sarcoma
January 23, 2021

Data published in Cancer the journal found that the response to neoadjuvant therapy in patients with retroperitoneal sarcoma following surgery was fair overall, with data suggesting the potential for disease progression as a predictive tool for patient survival.